Page last updated: 2024-11-04

sulfasalazine and Idiopathic Parkinson Disease

sulfasalazine has been researched along with Idiopathic Parkinson Disease in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research Excerpts

ExcerptRelevanceReference
"Sulfasalazine is an anti-inflammatory agent commonly used in the treatment of autoimmune conditions such as inflammatory bowel disease and rheumatoid arthritis."5.46Sulfasalazine-Induced Crystalluria Causing Severe Acute Kidney Injury. ( Durando, M; Kim, JS; Tiu, H, 2017)
"Sulfasalazine is an anti-inflammatory agent commonly used in the treatment of autoimmune conditions such as inflammatory bowel disease and rheumatoid arthritis."1.46Sulfasalazine-Induced Crystalluria Causing Severe Acute Kidney Injury. ( Durando, M; Kim, JS; Tiu, H, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durando, M1
Tiu, H1
Kim, JS1

Other Studies

1 other study available for sulfasalazine and Idiopathic Parkinson Disease

ArticleYear
Sulfasalazine-Induced Crystalluria Causing Severe Acute Kidney Injury.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017, Volume: 70, Issue:6

    Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Carbidopa;

2017